Search published articles


Showing 2 results for Toxicity

Samaneh Taghilou, Mirjamal Hosseini,
Volume 3, Issue 2 (10-2015)
Abstract

The dialkyl- or alkyl/aryl esters of 1, 2-benzenedicarboxylic acid, which are known as Phthalates, are high-production volume synthetic chemicals and considered as environmental pollutants, due to high production and uses in community, plastics industry and common consuming products. Di-(2-ethylhexyl) phthalate (DEHP) is the most abundant phthalate in the environment. Human exposure with DEHP could be done via different chemical compounds including food packaging, household furnishings, nutritional supplements, cleaning materials and insecticides. Besides, exposure of human with phthalates occurs through different pathways such as direct contact and using Phthalate-containing products, and indirectly through leaching into other products, or general environmental contaminations. Historically, the diet has been considered the major source of phthalate exposure in the general population, but in all sources, pathways, and their relative contributions to human exposures are not well understood. Medical devices are other source of significant exposure in human. Furthermore, cosmetics, personal care products, pharmaceuticals, nutritional supplements, herbal remedies and insecticides, may result in significant but poorly quantified human exposure with this compounds. In the present review article, we tried to discuss about metabolism of phthalates in human, toxicity, monitoring of phthalates in foods, environment, and cosmetic products and then metabolites of phthalates. Finally, evaluation of human exposure through biological control is discussed.


Hamideh Gharnas-Ghamesh, Mojtaba Masoumi, Vahid Erfani-Moghadam,
Volume 9, Issue 3 (10-2021)
Abstract

Background and Objective: Cancer is one of the most serious diseases. Doxorubicin is a type of chemotherapy drug used to treat a variety of cancers. Doxorubicin is a type of chemotherapy drug used to treat a variety of cancers. However, its side effects have limited its use. The aim of this study was to synthesize and evaluate polymer micelles containing doxorubicin and evaluate its toxicity on MCF7 breast cancer cells and HepG2 liver cancer cells.
Material and Methods: For this purpose, PBMA-b-POEGMA diblock copolymer was first synthesized using the RAFT method and confirmed by GPC. Dynamic light scattering (DLS) and Transmission electron microscope (TEM) were used to observe the morphology, size, and polydispersity of the micelles. In addition, in vitro cytotoxicity of DOX-loaded polymeric micelles against MCF7 cells and HepG2 cells were assessed. Furthermore, cell uptake and apoptosis assay of DOX-loaded polymeric micelles against MCF7 cells were evaluated.
Results: The TEM image revealed that the nanoparticles were spherical and uniform. The particle size and polydispersity measured by DLS were 35 nm and 0.13, respectively. The drug encapsulation efficiency and drug loading contents were 50±3.46 % and 4.53±0.29 %, respectively. The drug release rate was reported 69% in saline phosphate buffer (pH 7.4) within 24 hours. The results showed that micelles containing doxorubicin had a greater effect on MCF7 cell viability than the free drug. The MTT assay demonstrated that micelles were biocompatible to HepG2 cells while DOX-loaded micelles showed significant cytotoxicity. The IC50 of doxorubicin-loaded micelles against MCF7 cells were obtained to be 0.5 μg/ml. It was further shown that micelles containing doxorubicin had higher cell uptake and apoptosis than free drugs on MCF7 cells.
Conclusion: These polymeric micelles are an ideal candidate to deliver anticancer agents into breast cancer cells.


Page 1 from 1     

© 2024 CC BY-NC 4.0 | Jorjani Biomedicine Journal

Designed & Developed by : Yektaweb